What Has Been The Evolution of the Immunofluorescence Assay Market in Recent Years?
The immunofluorescence assay market has seen considerable growth due to a variety of factors.
• The market size for immunofluorescence assays has experienced substantial growth in the past few years. Its growth is projected to continue, increasing from $3.34 billion in 2024 to $3.59 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%.
This significant expansion during the historical period can be attributed to factors such as an increase in disease diagnosis, advancements in research and development, a surge in autoimmune diseases, a rise in cancer diagnostics, and an uptick in virology research.
What Is the Forecasted Market Size and Growth Rate for The Immunofluorescence Assay Market?
The immunofluorescence assay market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for immunofluorescence assays is predicted to experience a substantial increase in the upcoming years, expanding to a value of $5.4 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%.
Such growth during the forecast period can be linked to the rise in personalized medicine, escalating surveillance of infectious diseases, growing instances of autoimmune disorders, increasing point-of-care testing, and heightened global health preparedness. The forecast period is also projected to witness significant trends such as the prevalence of multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, and the integration of digital pathology.
What Factors Are Driving Growth In The Immunofluorescence Assay Market?
The surge in chronic diseases is considerably contributing to the expansion of the immunofluorescence assay market. Factors such as the shift in lifestyle, eating habits, and poor weight regulation are leading to a rapid increase in chronic conditions, and certain continuous chronic infections are posing a threat to cancer. It's anticipated that the rising frequency of chronic disease will spur the need for immunofluorescence assays since they are extensively utilized in identifying diseases and creating drugs. For instance, data from the Centers for Disease Control and Prevention indicate that around 6 out of 10 adults in the USA suffer from chronic disease, contributing $3.8 trillion in yearly healthcare costs. Hence, the escalating frequency of chronic diseases is likely to push the demand for the immunofluorescence assay in the forthcoming years.
What Are The Main Segments Of The Global Immunofluorescence Assay Market?
The immunofluorescence assay market covered in this report is segmented –
1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Hospitals And Diagnostic Centers
Subsegments:
1) By Direct Immunofluorescence: Single-Step Direct Assays, Multiplex Direct Assays
2) By Indirect Immunofluorescence: Single-Step Indirect Assays, Multiplex Indirect Assays
Pre-Book The Immunofluorescence Assay Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Immunofluorescence Assay Market?
The immunofluorescence assay market is experiencing accelerated popularity due to advancements in technology. Firms in this sector are focusing on developing innovative products technologically to meet special technical requirements for diagnosing new viruses such as COVID-19 and fortify their market standing. For example, in March 2022, LumiraDx, a UK developer of point-of-care diagnostics, received emergency authorization for its LumiraDx SARS-CoV-2 Ag Test, a microfluidic immunofluorescence assay crafted for the qualitative detection of nucleocapsid protein antigen from nasal swab specimens.
Who Are the Key Players in the Immunofluorescence Assay Market?
Major companies operating in the immunofluorescence assay market include:
• Thermo Fisher Scientific Inc.
• Abcam plc
• Bio-Rad Laboratories Inc.
• PerkinElmer Inc.
• Werfen Company
• Merck KGaA
• Danaher Corporation
• Cell Signaling Technology Inc.
• Vector Laboratories Inc.
• INOVA Diagnostics Inc.
• Sino Biological Inc.
• Medipan GmbH
• BioLegend Inc.
• Jackson ImmunoResearch Laboratories Inc.
• Rockland Immunochemicals Inc.
• Bethyl Laboratories Inc.
• Fitzgerald Industries International Inc.
• Creative Diagnostics
• Boster Biological Technology
• Acris Antibodies GmbH
• RayBiotech Inc.
• Proteintech Group Inc.
• Novus Biologicals LLC
• R&D Systems Inc.
• OriGene Technologies Inc.
• GenScript Biotech Corporation
• MBL International Corporation
• Abnova Corporation
• Cellabs India Technologies Limited
• J. Mitra & Co. Pvt. Ltd.
• EpiGentek Group Inc.
• Elabscience Biotechnology Co. Ltd.
• Aesku.Diagnostics GmbH
What Is The Most Dominant Region In The Immunofluorescence Assay Market?
North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
